BlueCrest Capital Management’s Cardiovascular Systems, Inc. CSII Stock Holding History

BlueCrest Capital Management’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,892	Closed	-$426K	–	1536
2018 Q3	$426K	Sell	10,892 -2,446	-18%	-$90.4K	0.01%	845
2018 Q2	$431K	Buy	13,338 +188	+1%	+$5.17K	0.01%	919
2018 Q1	$288K	Buy	+13,150	New	+$316K	0.01%	1087
2017 Q3	–	Sell	-6,339	Closed	-$204K	–	1144
2017 Q2	$204K	Buy	+6,339	New	+$193K	0.01%	766

Other funds holding CSII

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

BlueCrest Capital Management's CSII Position: Q4 2018 in Review

BlueCrest Capital Management sold out of Cardiovascular Systems, Inc. (CSII) in Q4 2018, closing a stake of 10,892 shares — an estimated $426K sold.

BlueCrest Capital Management first reported a position in CSII in Q2 2017 and held it in 4 quarters. The position peaked at $431K in Q2 2018. 148 funds tracked by Wall St. Rank hold CSII as of Q4 2018.

BlueCrest Capital Management reported no remaining Cardiovascular Systems, Inc. position as of Q4 2018 after selling out during the quarter.
BlueCrest Capital Management sold 10,892 Cardiovascular Systems, Inc. shares in Q4 2018, an estimated $426K.
BlueCrest Capital Management first reported a position in Cardiovascular Systems, Inc. in Q2 2017 and held it in 4 quarters.
BlueCrest Capital Management's Cardiovascular Systems, Inc. position peaked at $431K in Q2 2018.
148 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q4 2018.

Based on BlueCrest Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.